Hsf-1 affects podocyte markers NPHS1, NPHS2 and WT1 in a transgenic mouse model of TTRVal30Met-related amyloidosis

References

• Benson MD, Kincaid JC. The molecular biology and clinical features of amyloid neuropathy. Muscle Nerve 2007;36:411–23
   PubMed Web of Science ®Google Scholar
• Sobue G, Koike H, Misu K, Hattori N, Yamamoto M, Ikeda S, Ando Y, et al. Clinicopathologic and genetic features of early- and late-onset FAP type I (FAP ATTR Val30Met) in Japan. Amyloid 2003;10:32–8
   PubMed Web of Science ®Google Scholar
• Holmgren G, Costa PM, Andersson C, Asplund K, Steen L, Beckman L, Nylander PO, et al. Geographical distribution of TTR met30 carriers in northern Sweden: discrepancy between carrier frequency and prevalence rate. J Med Genet 1994;31:351–4
   PubMed Web of Science ®Google Scholar
• Sousa A, Coelho T, Barros J, Sequeiros J. Genetic epidemiology of familial amyloidotic polyneuropathy (FAP)-type I in Póvoa do Varzim and Vila do Conde (north of Portugal). Am J Med Genet 1995;60:512–21
   PubMed Web of Science ®Google Scholar
• Jennette JC, Heptinstall RH. Heptinstall’s pathology of the kidney. 6th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2007
   Google Scholar
• Lobato L, Beirão I, Silva M, Fonseca I, Queirós J, Rocha G, Sarmento AM, et al. End-stage renal disease and dialysis in hereditary amyloidosis TTR V30M: presentation, survival and prognostic factors. Amyloid 2004;11:27–37
   PubMed Web of Science ®Google Scholar
• Lobato L, Beirão I, Silva M, Bravo F, Silvestre F, Guimarães S, Sousa A, et al. Familial ATTR amyloidosis: microalbuminuria as a predictor of symptomatic disease and clinical nephropathy. Nephrol Dial Transplant 2003;18:532–8
   PubMed Web of Science ®Google Scholar
• Matsunaga N, Anan I, Rosenberg P, Nagai R, Lundström O, Horiuchi S, Ando Y, et al. Advanced glycation end product is implicated in amyloid-related kidney complications. Scand J Clin Lab Invest 2005;65:263–71
   PubMed Web of Science ®Google Scholar
• Moffat DB. New ideas on the anatomy of the kidney. J Clin Pathol 1981;34:1197–206
   PubMed Web of Science ®Google Scholar
• Patrakka J, Tryggvason K. Nephrin – a unique structural and signaling protein of the kidney filter. Trends Mol Med 2007;13:396–403
   PubMed Web of Science ®Google Scholar
• Putaala H, Soininen R, Kilpeläinen P, Wartiovaara J, Tryggvason K. The murine nephrin gene is specifically expressed in kidney, brain and pancreas: inactivation of the gene leads to massive proteinuria and neonatal death. Hum Mol Genet 2001;10:1–8
   PubMed Web of Science ®Google Scholar
• Kestilä M, Lenkkeri U, Männikkö M, Lamerdin J, McCready P, Putaala H, Ruotsalainen V, et al. Positionally cloned gene for a novel glomerular protein – nephrin – is mutated in congenital nephrotic syndrome. Mol Cell 1998;1:575–82
   PubMed Web of Science ®Google Scholar
• Furness PN, Hall LL, Shaw JA, Pringle JH. Glomerular expression of nephrin is decreased in acquired human nephrotic syndrome. Nephrol Dial Transplant 1999;14:1234–7
   PubMed Web of Science ®Google Scholar
• Welsh GI, Saleem MA. Nephrin-signature molecule of the glomerular podocyte? J Pathol 2010;220:328–37
   PubMed Web of Science ®Google Scholar
• Schwarz K, Simons M, Reiser J, Saleem MA, Faul C, Kriz W, Shaw AS, et al. Podocin, a raft-associated component of the glomerular slit diaphragm, interacts with CD2AP and nephrin. J Clin Invest 2001;108:1621–9
   PubMed Web of Science ®Google Scholar
• Kawachi H, Koike H, Kurihara H, Sakai T, Shimizu F. Cloning of rat homologue of podocin: expression in proteinuric states and in developing glomeruli. J Am Soc Nephrol 2003;14:46–56
   PubMed Web of Science ®Google Scholar
• Stylianou K, Petrakis I, Mavroeidi V, Stratakis S, Vardaki E, Perakis K, Stratigis S, et al. The PI3K/Akt/mTOR pathway is activated in murine lupus nephritis and downregulated by rapamycin. Nephrol Dial Transplant 2011;26:498–508
   PubMed Web of Science ®Google Scholar
• Bertelli R, Ginevri F, Caridi G, Dagnino M, Sandrini S, Di Duca M, Emma F, et al. Recurrence of focal segmental glomerulosclerosis after renal transplantation in patients with mutations of podocin. Am J Kidney Dis 2003;41:1314–21
   PubMed Web of Science ®Google Scholar
• Perysinaki GS, Moysiadis DK, Bertsias G, Giannopoulou I, Kyriacou K, Nakopoulou L, Boumpas DT, et al. Podocyte main slit diaphragm proteins, nephrin and podocin, are affected at early stages of lupus nephritis and correlate with disease histology. Lupus 2011;20:781–91
   PubMed Web of Science ®Google Scholar
• Li H, Lemay S, Aoudjit L, Kawachi H, Takano T. SRC-family kinase Fyn phosphorylates the cytoplasmic domain of nephrin and modulates its interaction with podocin. J Am Soc Nephrol 2004;15:3006–15
   PubMedGoogle Scholar
• Bariety J, Mandet C, Hill GS, Bruneval P. Parietal podocytes in normal human glomeruli. J Am Soc Nephrol 2006;17:2770–80
   PubMed Web of Science ®Google Scholar
• Morrison AA, Viney RL, Saleem MA, Ladomery MR. New insights into the function of the Wilms tumor suppressor gene WT1 in podocytes. Am J Physiol Renal Physiol 2008;295:F12–17
   Web of Science ®Google Scholar
• Moorthy AV, Chesney RW, Lubinsky M. Chronic renal failure and XY gonadal dysgenesis: “Frasier” syndrome – a commentary on reported cases. Am J Med Genet Suppl 1987;3:297–302
   PubMedGoogle Scholar
• Habib R, Loirat C, Gubler MC, Niaudet P, Bensman A, Levy M, Broyer M. The nephropathy associated with male pseudohermaphroditism and Wilms’ tumor (Drash syndrome): a distinctive glomerular lesion – report of 10 cases. Clin Nephrol 1985;24:269–78
   PubMed Web of Science ®Google Scholar
• Schumacher VA, Schlötzer-Schrehardt U, Karumanchi SA, Shi X, Zaia J, Jeruschke S, Zhang D, et al. WT1-dependent sulfatase expression maintains the normal glomerular filtration barrier. J Am Soc Nephrol 2011;22:1286–96
   PubMed Web of Science ®Google Scholar
• Cheng H, Harris RC. The glomerulus – a view from the outside – the podocyte. Int J Biochem Cell Biol 2010;42:1380–7
   PubMed Web of Science ®Google Scholar
• Trinklein ND, Murray JI, Hartman SJ, Botstein D, Myers RM. The role of heat shock transcription factor 1 in the genome-wide regulation of the mammalian heat shock response. Mol Biol Cell 2004;15:1254–61
   PubMed Web of Science ®Google Scholar
• Xiao X, Zuo X, Davis AA, McMillan DR, Curry BB, Richardson JA, Benjamin IJ. HSF1 is required for extra-embryonic development, postnatal growth and protection during inflammatory responses in mice. EMBO J 1999;18:5943–52
   PubMed Web of Science ®Google Scholar
• Santos SD, Fernandes R, Saraiva MJ. The heat shock response modulates transthyretin deposition in the peripheral and autonomic nervous systems. Neurobiol Aging 2010;31:280–9
   PubMed Web of Science ®Google Scholar
• Macedo B, Magalhães J, Batista AR, Saraiva MJ. Carvedilol treatment reduces transthyretin deposition in a familial amyloidotic polyneuropathy mouse model. Pharmacol Res 2010;62:514–22
   PubMed Web of Science ®Google Scholar
• Westermark GT, Johnson KH, Westermark P. Staining methods for identification of amyloid in tissue. Methods Enzymol 1999;309:3–25
   PubMed Web of Science ®Google Scholar
• Dorak T. Real-time PCR. New York; Abingdon, England: Taylor & Francis; 2006
   Google Scholar
• Stylianou K, Petrakis I, Mavroeidi V, Stratakis S, Kokologiannakis G, Lioudaki E, Liotsi C, et al. Rapamycin induced ultrastructural and molecular alterations in glomerular podocytes in healthy mice. Nephrol Dial Transplant 2012;27:3141–8
   PubMed Web of Science ®Google Scholar
• Hirose K, Osterby R, Nozawa M, Gundersen HJ. Development of glomerular lesions in experimental long-term diabetes in the rat. Kidney Int 1982;21:689–95
   PubMed Web of Science ®Google Scholar
• Barutta F, Pinach S, Giunti S, Vittone F, Forbes JM, Chiarle R, Arnstein M, et al. Heat shock protein expression in diabetic nephropathy. Am J Physiol Renal Physiol 2008;295:F1817–24
   Web of Science ®Google Scholar
• Smoyer WE, Ransom RF. Hsp27 regulates podocyte cytoskeletal changes in an in vitro model of podocyte process retraction. FASEB J 2002;16:315–26
   PubMed Web of Science ®Google Scholar
• Sanchez-Niño MD, Sanz AB, Sanchez-Lopez E, Ruiz-Ortega M, Benito-Martin A, Saleem MA, Mathieson PW, et al. HSP27/HSPB1 as an adaptive podocyte antiapoptotic protein activated by high glucose and angiotensin II. Lab Invest 2012;92:32–45
   PubMed Web of Science ®Google Scholar
• Pirkkala L, Nykänen P, Sistonen L. Roles of the heat shock transcription factors in regulation of the heat shock response and beyond. FASEB J 2001;15:1118–31
   PubMed Web of Science ®Google Scholar
• Sousa MM, Yan SD, Stern D, Saraiva MJ. Interaction of the receptor for advanced glycation end products (RAGE) with transthyretin triggers nuclear transcription factor kB (NF-kB) activation. Lab Invest 2000;80:1101–10
   PubMed Web of Science ®Google Scholar
• Sousa MM, Du Yan S, Fernandes R, Guimaraes A, Stern D, Saraiva MJ. Familial amyloid polyneuropathy: receptor for advanced glycation end products-dependent triggering of neuronal inflammatory and apoptotic pathways. J Neurosci 2001;21:7576–86
   PubMed Web of Science ®Google Scholar
• Busch M, Franke S, Rüster C, Wolf G. Advanced glycation end-products and the kidney. Eur J Clin Invest 2010;40:742–55
   PubMed Web of Science ®Google Scholar
• Yan K, Khoshnoodi J, Ruotsalainen V, Tryggvason K. N-linked glycosylation is critical for the plasma membrane localization of nephrin. J Am Soc Nephrol 2002;13:1385–9
   PubMedGoogle Scholar
• Cybulsky AV. Endoplasmic reticulum stress in proteinuric kidney disease. Kidney Int 2010;77:187–93
   PubMed Web of Science ®Google Scholar
• Suzuki T, Matsusaka T, Nakayama M, Asano T, Watanabe T, Ichikawa I, Nagata M. Genetic podocyte lineage reveals progressive podocytopenia with parietal cell hyperplasia in a murine model of cellular/collapsing focal segmental glomerulosclerosis. Am J Pathol 2009;174:1675–82
   PubMed Web of Science ®Google Scholar
• Lemley KV, Lafayette RA, Safai M, Derby G, Blouch K, Squarer A, Myers BD. Podocytopenia and disease severity in IgA nephropathy. Kidney Int 2002;61:1475–85
   PubMed Web of Science ®Google Scholar
• Sousa MM, Cardoso I, Fernandes R, Guimarães A, Saraiva MJ. Deposition of transthyretin in early stages of familial amyloidotic polyneuropathy: evidence for toxicity of nonfibrillar aggregates. Am J Pathol 2001;159:1993–2000
   PubMed Web of Science ®Google Scholar